ZA200109848B - Novel anti-allergic agents. - Google Patents
Novel anti-allergic agents.Info
- Publication number
- ZA200109848B ZA200109848B ZA200109848A ZA200109848A ZA200109848B ZA 200109848 B ZA200109848 B ZA 200109848B ZA 200109848 A ZA200109848 A ZA 200109848A ZA 200109848 A ZA200109848 A ZA 200109848A ZA 200109848 B ZA200109848 B ZA 200109848B
- Authority
- ZA
- South Africa
- Prior art keywords
- allergic agents
- segment
- abolish
- novel anti
- reduce
- Prior art date
Links
- 239000000043 antiallergic agent Substances 0.000 title abstract 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 abstract 2
- 210000003630 histaminocyte Anatomy 0.000 abstract 2
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229960001340 histamine Drugs 0.000 abstract 1
- 230000035515 penetration Effects 0.000 abstract 1
- 239000000816 peptidomimetic Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4722—G-proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Wood Science & Technology (AREA)
- Pulmonology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Mycology (AREA)
- Rheumatology (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL13052699A IL130526A0 (en) | 1999-06-17 | 1999-06-17 | Novel anti-allergenic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200109848B true ZA200109848B (en) | 2003-02-26 |
Family
ID=11072936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200109848A ZA200109848B (en) | 1999-06-17 | 2001-11-29 | Novel anti-allergic agents. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20110143995A1 (ja) |
| EP (2) | EP1891969A3 (ja) |
| JP (1) | JP2003502385A (ja) |
| AT (1) | ATE447966T1 (ja) |
| AU (1) | AU764581B2 (ja) |
| CA (1) | CA2377524A1 (ja) |
| DE (1) | DE60043301D1 (ja) |
| IL (2) | IL130526A0 (ja) |
| NZ (1) | NZ516605A (ja) |
| WO (1) | WO2000078346A1 (ja) |
| ZA (1) | ZA200109848B (ja) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL140473A0 (en) | 2000-12-21 | 2002-02-10 | Allergene Ltd | Anti-allergic complex molecules |
| IL130526A0 (en) * | 1999-06-17 | 2000-06-01 | Allergene Ltd | Novel anti-allergenic agents |
| JP4498101B2 (ja) * | 2004-11-04 | 2010-07-07 | 大鵬薬品工業株式会社 | 頭痛の予防及び／または治療剤 |
| WO2010137012A1 (en) | 2009-05-25 | 2010-12-02 | Ramot At Tel-Aviv University Ltd. | Peptide therapy for amphiregulin mediated diseases |
| US20120070449A1 (en) | 2009-05-28 | 2012-03-22 | Yeda Research And Development Co. Ltd. | Methods of treating inflammation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5807746A (en) * | 1994-06-13 | 1998-09-15 | Vanderbilt University | Method for importing biologically active molecules into cells |
| US6103692A (en) * | 1996-03-12 | 2000-08-15 | The General Hospital Corporation | Inhibiting protein interactions |
| IL140473A0 (en) * | 2000-12-21 | 2002-02-10 | Allergene Ltd | Anti-allergic complex molecules |
| IL130526A0 (en) * | 1999-06-17 | 2000-06-01 | Allergene Ltd | Novel anti-allergenic agents |
-
1999
- 1999-06-17 IL IL13052699A patent/IL130526A0/xx unknown
-
2000
- 2000-06-14 CA CA002377524A patent/CA2377524A1/en not_active Abandoned
- 2000-06-14 WO PCT/IL2000/000346 patent/WO2000078346A1/en active Application Filing
- 2000-06-14 AT AT00937154T patent/ATE447966T1/de not_active IP Right Cessation
- 2000-06-14 EP EP07022898A patent/EP1891969A3/en not_active Withdrawn
- 2000-06-14 EP EP00937154A patent/EP1191943B1/en not_active Expired - Lifetime
- 2000-06-14 DE DE60043301T patent/DE60043301D1/de not_active Expired - Lifetime
- 2000-06-14 JP JP2001504408A patent/JP2003502385A/ja active Pending
- 2000-06-14 NZ NZ516605A patent/NZ516605A/xx unknown
- 2000-06-14 AU AU52438/00A patent/AU764581B2/en not_active Ceased
-
2001
- 2001-11-29 ZA ZA200109848A patent/ZA200109848B/xx unknown
-
2008
- 2008-01-06 IL IL188610A patent/IL188610A0/en unknown
-
2010
- 2010-11-09 US US12/942,900 patent/US20110143995A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1191943B1 (en) | 2009-11-11 |
| EP1191943A1 (en) | 2002-04-03 |
| NZ516605A (en) | 2004-03-26 |
| JP2003502385A (ja) | 2003-01-21 |
| CA2377524A1 (en) | 2000-12-28 |
| WO2000078346A1 (en) | 2000-12-28 |
| AU5243800A (en) | 2001-01-09 |
| DE60043301D1 (de) | 2009-12-24 |
| EP1891969A2 (en) | 2008-02-27 |
| AU764581B2 (en) | 2003-08-21 |
| IL130526A0 (en) | 2000-06-01 |
| US20110143995A1 (en) | 2011-06-16 |
| EP1191943A4 (en) | 2004-10-13 |
| ATE447966T1 (de) | 2009-11-15 |
| IL188610A0 (en) | 2008-04-13 |
| EP1891969A3 (en) | 2008-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69433562D1 (de) | Prosaposin und cytokinabhängige peptide als therapeutisch wirksame mittel | |
| EP1329458A3 (en) | Peptides that lower blood glucose levels | |
| CA2323086A1 (en) | Regulation of endogenous gene expression in cells using zinc finger proteins | |
| IL188610A0 (en) | Novel anti-allergic agents | |
| ES2175460T3 (es) | Compuesto de lipoxinas y su utilizacion en el tratamiento de patologias con proliferacion celular. | |
| MXPA04005266A (es) | Inmunocitocinas con selectividad modulada. | |
| BR0209292A (pt) | Uso compostos de complexos de metais como catalisadores de oxidação | |
| WO2003096972A3 (en) | Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof | |
| AU2433901A (en) | Chimeric natriuretic peptides | |
| CA2318398A1 (en) | Novel peptides having biological activity | |
| WO2001055411A3 (en) | Human sulfatases | |
| WO2000069884A3 (en) | Compositions isolated from skin cells and methods for their use | |
| WO2001045650A3 (de) | Kosmetische verwendung von rückständen aus der weinherstellung | |
| WO2002050097A3 (en) | Anti-allergic complex molecules | |
| WO2000066732A3 (en) | Laminin 8 and methods for its use | |
| WO2001045738A3 (en) | Use of heat shock proteins to enhance production of chemokines by a cell | |
| NZ320240A (en) | Fungal Cellulases, vectors & uses thereof | |
| AU4747497A (en) | Sordarin derivatives | |
| DE60139113D1 (de) | 18477, eine menschliche proteinkinase und deren verwendung | |
| AU6917700A (en) | Use of colostrinin, constituent peptides thereof, and analogs thereof to promoteneural cell differentiation | |
| PL338678A1 (en) | Derivatives of 4-cyano-4-deformylsordacin | |
| MX9605402A (es) | Nueva sustancia activa peptidica y su obtencion. | |
| ATE528392T1 (de) | Neues protein und dessen dns | |
| PL338704A1 (en) | Derivatives of 4-cyano-4-deformylsordarin | |
| WO2002068668A3 (en) | Compositions and methods for production cell culture |